TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 515.16B
Enterprise Value 349.31B
Trailing P/E -2.44
Forward P/E 13.96
PEG Ratio (5 yr expected) 1-0.51
Price/Sales (ttm)0.65
Price/Book (mrq)0.62
Enterprise Value/Revenue 32.11
Enterprise Value/EBITDA 66.64

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin -25.19%
Operating Margin (ttm)23.35%
Management Effectiveness
Return on Assets (ttm)4.73%
Return on Equity (ttm)-19.12%
Income Statement
Revenue (ttm)23.37B
Revenue Per Share (ttm)23.23
Quarterly Revenue Growth (yoy)12.90%
Gross Profit (ttm)11.86B
EBITDA 7.42B
Net Income Avi to Common (ttm)-6.14B
Diluted EPS (ttm)-6.11
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)599M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)35.05B
Total Debt/Equity (mrq)118.39
Current Ratio (mrq)0.94
Book Value Per Share (mrq)23.99
Cash Flow Statement
Operating Cash Flow (ttm)4.1B
Levered Free Cash Flow (ttm)4.2B

Trading Information

Stock Price History
Beta 0.72
52-Week Change 3-66.77%
S&P500 52-Week Change 319.62%
52 Week High 344.42
52 Week Low 314.30
50-Day Moving Average 316.59
200-Day Moving Average 325.64
Share Statistics
Avg Vol (3 month) 324.14M
Avg Vol (10 day) 317.2M
Shares Outstanding 51.02B
Float 909.68M
% Held by Insiders 19.89%
% Held by Institutions 159.96%
Shares Short 337.94M
Short Ratio 34.71
Short % of Float 30.00%
Shares Short (prior month) 331.56M
Dividends & Splits
Forward Annual Dividend Rate 41.1
Forward Annual Dividend Yield 47.50%
Trailing Annual Dividend Rate 31.11
Trailing Annual Dividend Yield 37.56%
5 Year Average Dividend Yield 42.96
Payout Ratio 40.00%
Dividend Date 3Sep 14, 2017
Ex-Dividend Date 4Aug 25, 2017
Last Split Factor (new per old) 22/1
Last Split Date 3Jul 1, 2004